adreogen

About adreogen

The startup develops topical androgen therapies that specifically target Relapse-Initiating Cells (RICs) in leukemia patients to prevent drug resistance and relapse. By focusing on these critical cells, the therapies aim to enhance patient health outcomes and improve overall treatment efficacy.

What does adreogen do?

The startup develops topical androgen therapies that specifically target Relapse-Initiating Cells (RICs) in leukemia patients to prevent drug resistance and relapse. By focusing on these critical cells, the therapies aim to enhance patient health outcomes and improve overall treatment efficacy.

Where is adreogen located?

adreogen is based in Toulouse, France.

When was adreogen founded?

adreogen was founded in 2024.

Location
Toulouse, France
Founded
2024
Employees
1 employees
Looking for specific startups?
Try our free semantic startup search

adreogen

Score: 40/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

The startup develops topical androgen therapies that specifically target Relapse-Initiating Cells (RICs) in leukemia patients to prevent drug resistance and relapse. By focusing on these critical cells, the therapies aim to enhance patient health outcomes and improve overall treatment efficacy.

adreogen.com200+
Founded 2024 – Toulouse, France

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (<5)

No team information available. Click "Fetch founders" to run a focused founder search.
adreogen | StartupSeeker